Products3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
OLANZAPINE
Product Details
NDC Product Code
50268-616Application Number
ANDA091415Marketing Category
ANDA (C73584)Route of Administration
ORALEffective Date
November 7, 2023ASPARTAMEInactive
Code: Z0H242BBR1Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
OlanzapineActive
Code: N7U69T4SZRClass: ACTIBQuantity: 10 mg in 1 1
OLANZAPINE
Product Details
NDC Product Code
50268-615Application Number
ANDA091415Marketing Category
ANDA (C73584)Route of Administration
ORALEffective Date
November 7, 2023CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
ASPARTAMEInactive
Code: Z0H242BBR1Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
OlanzapineActive
Code: N7U69T4SZRClass: ACTIBQuantity: 5 mg in 1 1
OLANZAPINE
Product Details
NDC Product Code
50268-617Application Number
ANDA091415Marketing Category
ANDA (C73584)Route of Administration
ORALEffective Date
November 7, 2023CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
ASPARTAMEInactive
Code: Z0H242BBR1Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
OlanzapineActive
Code: N7U69T4SZRClass: ACTIBQuantity: 15 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT